Tissue-Engineered Cochlear Fibrosis Model Links Complex Impedance to Fibrosis Formation for Cochlear Implant Patients

Area of Science:

• Biomedical Engineering
• Otolaryngology
• Neuroscience

Background:

• Cochlear implants restore hearing but can cause immune responses leading to cochlear fibrosis.
• Fibrosis can cause hearing loss and reduce implant effectiveness.
• Current methods for tracking fibrosis are invasive or require postmortem analysis.

Purpose of the Study:

• To develop a tissue-engineered model of cochlear fibrosis.
• To identify electrical markers associated with fibrosis around cochlear implant electrodes.
• To establish a non-invasive method for real-time fibrosis monitoring in patients.

Main Methods:

• A tissue-engineered model of cochlear fibrosis was created.
• Electrochemical impedance spectroscopy (EIS) was used to characterize the model.
• A novel electrical marker was derived from voltage waveform responses.
• The marker was tested in a small cohort of cochlear implant patients.

Main Results:

• EIS revealed increased resistance and decreased capacitance in fibrotic tissue.
• A new marker based on complex impedance was identified.
• This marker showed a significant increase over two postoperative timepoints in patients.
• The marker is directly measurable from cochlear implant devices.

Conclusions:

• Complex impedance is a viable marker for tracking cochlear fibrosis progression.
• This non-invasive method allows for real-time monitoring of fibrosis.
• Early detection of fibrosis can lead to timely interventions and improved cochlear implant outcomes.